Introduction
The c-fos gene encodes a basic region-leucine zipper transcription factor that requires heterodimerization with a member of the Jun family for stable DNA binding. Fos/Jun heterodimers are present in the AP-1 transcription factor complex and both c-Fos and c-Jun are capable of transforming cells (1) . Continuous expression of c-fos can lead to aberrant differentiation (2) but may also sometimes block differentiation (3). Furthermore, antisense c-fos RNA or microinjected Fosspecific antibodies are able to inhibit cell growth (4-6). The study of the regulation of the c-fos gene may therefore provide important clues as to how cellular differentiation and proliferation are controlled.
The c-fos proto-oncogene is a member of the class of cellular immediate early genes which are rapidly and transiently induced upon stimulation of quiescent cells with growth factors or serum (7-9). In addition to these mitogens, many nonmitogenic signals such as UV-light (10) can also induce c-fos in a similar fashion. This transcriptional induction is independent of de novo synthesized proteins and inhibition of protein synthesis leads to an even stronger and prolonged induction of c-fos (11), indicating that components already exist for signal transduction cascades which target the c-fos promoter. Three proximal elements within the c-fos promoter have been identified as major targets for stimulating signals ( Figure 1 ): the sis inducible element (SIE*) (12,13), the serum response element (SRE) (14,15) and the cAMP response element (CRE) (15). In the following, the pathways and mechanisms of signaling to these three promoter elements and their binding proteins will be discussed.
The sis inducible element (SIE)
The SIE has been shown to confer c-fos induction by conditioned medium from \-sis transformed cells. The plateletderived growth factor (PDGF) B-chain gene is the cellular homolog of v-sis, and consistently the SIE is also responsive to PDGF (12,13). In addition, the SIE is involved in the stimulation of the c-fos gene by epidermal growth factor (EGF)
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(16,17) as well as by interleukin-2 and -6 (18,19). However, PDGF, EGF and interleukin-2 also target the c-fos SRE (20-22), indicating that the SIE and the SRE can collaborate. It may even be that both the SIE and the SRE are required for c-fos upregulation in response to these agents as has been shown for interleukin-2 signaling via p56 /c * (18), a protein tyrosine kinase of the Src family.
Inducible binding of the protein aggregate SIF (sis inducible factor) to the SIE has been observed in vitro and in vivo (12, 23, 24) . Three different complexes of SIF can be resolved in gel retardation assays (16), of which the SIF-A and SIF-B complexes, but not the SIF-C complex, avidly interact with the native c-fos SIE (19). Subsequent analyses have indicated diat two members of the Stat (signal transducer and activator of transcription) family form the SIF complexes: SIF-A is a homodimer of Stat3, SIF-C is a homodimer of Statla and SIF-B is a heterodimer of Statla and Stat3 (16, 19, 25) .
Stat proteins were discovered as mediators of signaling induced by interferon-a (IFN-a) and interferon-y (IFN-y) (26). They are latent monomeric cytoplasmic transcription factors which dimerize and move into the cell nucleus upon tyrosine phosphorylation. The IFN-a response is mediated by ISGF3 (IFN-a-stimulated gene factor 3) which is composed of p48, of Stat2 (also called Statl 13) and of either Statla (also called Stat91) or the C-terminal splice variant Statip (also called Stat84) (Figure 2A ). The p48 protein mediates direct binding to an ISRE (interferon stimulation response element) and apparently 'piggy-backs' a heterodimer of Statl and Stat2. Since all known Stat proteins possess a Src homology region 2 (SH2) domain that can interact with phosphotyrosyl peptides, this heterodimerization may be mediated via reciprocal intermolecular SH2-phosphotyrosyl peptide interactions similar to the homodimerization of Statl (27). Furthermore, Statla and Statl(3 homodimers can bind to an IFN-y-activated site (GAS) and thereby mediate the IFN-y response (Figure 2A ). However, while the Statla dimer activates transcription, the Stat 1(3 dimer apparently serves the function of a repressor. IFN-y leads only to tyrosine phosphorylation of Statla and Statip Statl by recruiting these factors into the ISGF3 complex, is only formed upon IFN-a, but not upon IFN-y stimulation, thereby dictating the specificity of the interferon response (26). Tyrosine phosphorylation of Stats is proposed to be exerted by Jaks (Janus kinase or just 'another kinase'), which are characterized by the presence of two kinase-like domains, the more C-terminal of which possesses tyrosine kinase activity (28). While binding of IFN-a to its cognate receptor activates the tyrosine kinases Jakl and Tyk2 but not Jak2, IFN-y leads to the activation of Jakl and Jak2 but not of Tyk2 ( Figure  2A ). However, it is presently unknown which of these kinases phosphorylates the different Stat proteins or whether other kinases are involved in vivo. Figure 2B outlines how the Statla and Stat3 proteins are activated and mediate SIE-dependent transcriptional upregulation. Binding of EGF to its cognate receptor leads to dimerization and tyrosine phosphorylation of the EGF receptor. One report suggests that Statla interacts via its SH2 domain with the tyrosine-phosphorylated EGF receptor and thereby itself becomes phosphorylated by the kinase domain of the receptor (17). However, it is also possible that Statla and Stat3 are phosphorylated by an unidentified tyrosine kinase which itself interacts with the activated EGF receptor. Activation of the SIE by interleukin-2 must involve such an intracellular tyrosine kinase because the interleukin-2 receptor lacks intrinsic kinase activity. One candidate is p56' c *, which has been shown to physically interact with a domain of the interleukin-2 receptor P chain (18,29). Another candidate is Jakl (30) and a third is Jak3, which requires a different domain of the interleukin-2 receptor (3 chain in order to become activated (31). Finally, induction of the SIE does not always involve both the Stat3 homodimer and Statl a/Stat3 heterodimer as observed upon EGF stimulation. For instance, interleukin-6 stimulation only results in the formation of Stat3 homodimers, possibly because Statla does not become phosphorylated (19).
The serum response element (SRE)
The SRE was originally demonstrated to mediate serum induction of the c-fos promoter (14). Serum can be regarded as a complex mixture of different growth factors and other mitogens, and individual growth factors such as PDGF (20) and EGF (21) can similarly induce c-fos. Cytokines like interleukin-2 (22) as well as the phorbol ester TPA (12-0-tetradecanoylphorbol 13-acetate) (10,20,21), UV-light (10), oxidants (32) and antioxidants (33) also activate the SRE.
The mechanism of growth factor-stimulated c-fos expression typically starts with the dimerization of growth factor receptor subunits upon ligand binding and their subsequent autophosphorylation on intracellular tyrosine residues (34). SH2 containing molecules can then interact with such phosphotyrosyl peptides and may themselves recruit other molecules to the activated growth factor receptor. The adapter molecule Grb2 not only contains an SH2 domain, but has in addition an SH3 (Src homology region 3) domain by which it interacts with a proline-rich domain of Sos (Figure 3 ). This protein is a guanine nucleotide exchange factor and catalyzes the transformation of the inactive GDP-Ras to the active GTPRas (35, 36) , which then recruits Raf-1 to the plasma membrane leading somehow to its activation (37, 38) . Apparently, Raf-1 can be activated in the absence of GTP-Ras provided that Raf-1 is localized to the plasma membrane (39, 40) , indicating that an unknown plasma membrane associated factor activates Raf-1. This factor may be the C, isoform of protein kinase C (PKC) (41) , which could cause activation of Raf-1 by direct phosphorylation. Furthermore, members of the 14-3-3 protein family may associate with Raf-1 and could thereby be involved in the activation of Raf-1 (42, 43) .
Phosphorylation of Raf-1 by PKC isoforms has been shown for PKCa, P and y (44, 45) , all of which belong to the diacylglycerol-dependent PKC subclass in contrast to the L, isoform (46, 47) . This explains the induction of c-fos by the diacylglycerol analog TPA: after permeation of the plasma membrane, TPA interacts with and thereby activates diacylglycerol-dependent PKC isoforms, one or more of which may then initiate Raf-1-dependent signal transduction pathways ( Figure 3 ).
Activated Raf-1 triggers a signal transduction cascade targeting the c-fos SRE (48, 49) and is at the top of the mitogenactivated protein kinase (MAPK) pathway ( Figure 3 ) (50) (51) (52) . Raf-1 phosphorylates MEKs (MAPK kinases) which themselves are dual-specificity kinases phosphorylating both a threonine and a tyrosine in MAPKs (53) . Several different MAPKs exist (54) and this complexity may even be enhanced by the family of the related Jun kinases (JNKs), also called stress-activated protein kinases (SAPKs) (55, 56) . Similarly, at least two functional MEKs have been identified in humans (57) , and Raf-1 may be replaced by A-Raf or B-Raf (38, 58) .
In addition to Raf, MEK kinase (MEKK) and Mos can trigger the MAPK pathway (Figure 3) (59, 60) . While it is presently unclear how Mos itself is activated, MEKK is stimulated by growth factors in a Ras-depedent manner (61) and possibly also by G proteins (59) , which are coupled to serpentine receptors (62) . Additionally, some G proteins activate the MAPK pathway via Ras (63) (64) (65) . Furthermore, MAPK has been shown to be phosphorylated and activated by p56' ct in vitro (66) . Since p56 /c * physically interacts with the interleukin-2 receptor (3 chain, it may be activated upon binding of interleukin-2 to its cognate receptor (18,29) and then directly stimulate MAPKs. Finally, oxidants, antioxidants or UV-light lead to the activation of MAPKs (67,68, J.Muller, M.A.C., P.Baeuerle and A.N., in preparation), although it is presently unknown how the MAPK pathway is triggered by these agents. However, Src, Ras and Raf-1 have been implicated in the activation of MAPK by UV-light. Once stimulated, MAPK enters the nucleus (69,70) and phosphorylates serine and threonine residues on various substrates including ternary complex factors (TCFs), thereby activating their potential to stimulate transcription (71) (72) (73) (74) (75) . Only in conjunction with the serum response factor (SRF) do TCFs interact with the c-fos SRE (76) ( Figure 4A ). Since the c-fos SRE is occupied by TCF and SRF before, during and after induction (24,77), phosphorylation of TCFs may occur in situ at the c-fos promoter. However, it could also involve the rapid exchange of proteins bound to the promoter.
Several different TCFs have been identified ( Figure 4B ): Elk-1 (78), the two splice variants Sap-la and Sap-lb (79) and Erp/Net (80, 81) . These proteins represent a subclass of the Ets family which is characterized by a DNA binding ETSdomain interacting with sites possessing a GGA A / T core sequence (82, 83) . TCFs are able to tightly bind certain Ets target sites (84, 85) but not the c-fos SRE that contains an Ets binding site with a GGAT core sequence ( Figure 4A ). Only additional protein-protein contacts with SRE-bound SRF via the homologous region B allows stable binding of. TCFs to the c-fos SRE (82, (85) (86) (87) (88) .
TCFs feature a third homologous region at the C-terminus (region C), which harbours several in vivo MAPK phosphorylation sites (89) . Although there are more MAPK sites on both sides of region C, those within the region C most strongly affect transactivation (72) (73) (74) (75) . Since Sap-lb lacks the C-terminal half of region C, which appears to be indispensable for transactivation (87) , it may represent a non-activatable TCF. Yet the functional diversity of TCFs is poorly understood. There is a certain tissue specific expression of TCFs, however in some organs all of them are expressed (81) . It was suggested that distinct signal transduction pathways preferentially target different TCFs (90) . In contrast to TCFs, dimerized SRF can autonomously interact with the c-fos SRE (91) . Several phosphorylation sites have been mapped within SRF (92) (93) (94) (95) (96) , however only the one at Serl03 has been shown to be induced upon growth factor stimulation and could be phosphorylated by the kinase pp90™* in vitro (97) . Since pp90"* is a target for MAPKs (98) , future experiments should unravel whether inducible phosphorylation of SRF at Serl03 or other positions contributes to c-fos activation via the SRE.
Interestingly, TCF dephosphorylation coincides with the down-regulation of c-fos after its induction, and both TCF dephosphorylation and c-fos down-regulation are blocked in the presence of the protein phosphatase inhibitor okadaic acid (99) . TCF dephosphorylation could be due to constitutive serine/threonine phosphatases such as protein phosphatase 2A (99) or potentially also to an inducible phosphatase. This would imply that a net phosphorylation of TCFs is only feasible when MAPKs are more active on TCFs than these phosphatases. MAPKs themselves are only transiently stimulated and their dephosphorylation can be caused by dual specificity (serine/threonine and tyrosine) phosphatases such as 3CH134/CL100 (100,101) or PAC1 (102) . These protein phosphatases are inducible by stimuli known to also induce c-fos (100-102). Thus they could be responsible for the transient nature of MAPK activation, and consequently also for the transient phosphorylation of TCFs and the transient transcriptional induction of c-fos. Indeed, constitutively active PAC1 has been demonstrated to oppose the activating effect of MAPKs on the c-fos SRE (103).
Other mechanisms could also contribute to post-inductional repression of c-fos. One proposed mechanism is squelching via a low abundance coactivator necessary for induced transcription via the SRE, which could involve SRF or c-Fos itself (104) . Both of these transcription factors are elevated in their concentration shortly after the transcriptional induction of cfos, and both proteins have been shown to repress SREdependent transcription, c-Fos even independently of its DNA binding domain. Another proposed mechanism is that newly synthesized SRF may bind the SRE in a hypophosphorylated state, thereby contributing to c-fos down-regulation (105).
The cAMP response element (CRE)
The c-fos CRE represents a binding site for CREB (CRE binding protein) and related transcription factors. CREB contains a basic region-leucine zipper motif that is responsible for dimerization and DNA binding (106) . Transactivation exerted by CREB requires phosphorylation on Serl33 (107) since only the phosphorylated form of CREB is capable of interaction with CBP (CREB binding protein), a coactivator thought to be required for the establishment of contacts with the transcriptional machinery (108) (109) (110) . CREB is a well established target of protein kinase A (PKA) that itself is activated by the second messenger cAMP (111) . Accordingly, the c-fos CRE is involved in transcriptional upregulation in response to cAMP (112) .
Signal transduction via PKA is often initiated at the plasma membrane upon interaction of a ligand (for instance the neurotransmitter nicotine) with a G protein-coupled serpentine receptor ( Figure 5 ). This induces the dissociation of heterotrimeric G proteins into Ga subunits and Gpy components leading to the activation of adenylyl cyclase (62) . Adenylyl cyclase converts ATP into cAMP which interacts with the regulatory subunits of the inactive cytoplasmic form of PKA. cAMP binding results in the dissociation of the catalytic subunits of PKA, which can then translocate to the nucleus, phosphorylate CREB on Serl33 and thus activate CRE-dependent transcription (111) . Similar to TCFs, the phosphorylation status of CREB determines the degree of transcriptional activity, and a constitutively active serine/threonine phosphatase (protein phosphatase 1) may dephosphorylate CREB in vivo, thereby attenuating CRE-driven transcription (113) .
Membrane depolarization, which leads to an influx of Ca 2+ , results in the phosphorylation of CREB and the induction of c-fos via the CRE in neuronal PC 12 cells. However, membrane depolarization does not significantly enhance intracellular cAMP levels, indicating that a signal transduction pathway independent of PKA is utilized (114) . Several lines of evidence argue for the activation of Ca 2+ /calmodulin-dependent protein kinases (CaMKs) by Ca 2+ influx and subsequent phosphorylation of CREB by CaMKs ( In addition, nerve growth factor (NGF) has been shown to stimulate c-fos transcription in PC 12 cells by phosphorylation of CREB on Serl33 which appears to be independent of PKA and CaMKs ( Figure 5 ). Rather, an unknown Ras-dependent protein kinase seems to be involved (118) . Since the NGF receptor is a classical growth factor receptor tyrosine kinase, it is likely that binding of its cognate ligand recruits Ras via Grb2 and Sos or other SH2-containing adaptor systems (36) .
Redundant targeting of the c-fos promoter?
As described above, most signals targeting the c-fos SFE have been shown to also stimulate the SRE. Similarly, Ca 2+ , cAMP and NGF not only activate the c-fos CRE but also the SRE (21,119,120) . Why do signals often target more than one element in the c-fos promoter? One answer might be to ensure that even weak stimulants activate c-fos. Furthermore it appears that signaling to the c-fos promoter may nearly always involve the SRE, identifying this element as the pivotal regulatory sequence. However, in hippocampal neurons Ca 2+ may activate two distinct signaling pathways depending on its mode of entry into neurons. Ca 2+ entry via the NMDA receptor seems to activate preferentially the c-fos SRE and only very slightly the c-fos CRE, while this situation is reversed upon Ca 2+ entry through a voltage-gated L-type Ca 2+ channel (121) . This example serves to illustrate that the other c-fos promoter elements may also function independently of a simultaneous activation of the SRE.
c-fos activation due to cAMP is apparently just as complex. The induction of PKA by cAMP, which leads to the activation of the c-fos CRE, has been shown to block the Ras-dependent activation of Raf-1 and thus the MAPK pathway in some cell lines, probably by inhibition of Raf-1 by PKA (122) (123) (124) . This suggests that cAMP-mediated induction of c-fos could be mediated solely by the CRE, because any potential MAPKmediated stimulation of the c-fos SRE would be attenuated. However, cAMP has been demonstrated to activate MAPK independently of Raf-1 in PC12 cells (125) . This mechanism is thus apparently distinct from the Ras-dependent activation of MAPK induced by certain G proteins (63) (64) (65) 126) . It was speculated that this effect may be mediated by either action of PKA or by cAMP-gated ion channels. Therefore, the CRE and the SRE may also jointly up-regulate c-fos transcription in certain cell lines. Thus, signal transduction pathways targeting the c-fos promoter may be cooperative or antagonistic depending on the cell-type studied.
Biological function of the Fos protein
The Fos protein, as part of the AP-1 transcription factor complex, has been implicated in cell proliferation and transformation, particularly in the transition from the GQ to Gi phases of the cell-cycle (1, 127 ). Yet homozygous c-fos knockout mice, although displaying some defects in bone formation and the haematopoietic system, can mature to adulthood (128, 129) , indicating that c-Fos is not absolutely indispensable. Clearly, Fos overexpression in transgenic mice induces bone tumors (130), demonstrating the potential of c-fos to be oncogenic in vivo. However, Fos-induced transformation is not dependent on expression at particular stages of the cell cycle, rather it is related to the duration of Fos expression (131) . These results suggest that the main function of Fos is not to regulate the expression of important determinants of the cell-cycle. Arguments for and against the involvement of c-Fos in cell-cycle control have been summarized by Hesketh (132) .
Activation of signal transduction pathways variably changes patterns of gene expression and metabolism, often leading to greatly increased consumption of ATP. Mitochondrial ATP synthesis is accompanied by the generation of toxic reactive oxygen intermediates (133) . Indeed, up to 2-5% of the oxygen reduced by mitochondria may be released to form H 2 O 2 (134). Thus, increased metabolism following cell stimulation could induce redox stress. Interestingly, many of the genes induced by redox stress contain AP-1 binding sites which confer this responsiveness. This is the case from yeast to mammals (135) (136) (137) (138) (139) , suggesting that one conserved and pivotal function of AP-1 transcription factors is the maintenance of intracellular redox homeostasis. This may explain why c-fos induction is coupled to almost any cellular stimulus: it may primarily serve to induce the provisionary up-regulation of AP-1 stimulated redox stress enzymes, whose function is to detoxify the undesirable products of potential metabolic changes. How might this relate to Fos-mediated transformation? As well as inducing stress, reactive oxygen intermediates have been harnessed during evolution to activate signaling pathways as natural second messengers. This applies to both oxidative and reducing conditions (140). Some evidence exists to suggest that reactive oxygen intermediate levels can influence transformation. The activity of some enzymes of glutadiione metabolism correlates well with a transforming phenotype (135, 141) . Furthermore redox stress can induce DNA-synthesis (32, 142, 143) , and reactive oxygen levels are thought to play a role in neoplasmic promotion (144 
